Investigations of amphiphilic butylglyceryl‐functionalized dextran nanoparticles for topical delivery

Toward the development of colloidal systems that can enhance transdermal permeation of hydrophilic actives, a material combining the non‐toxic of dextran with alkylglycerols permeation enhancing property has been designed. To this purpose, a range of amphiphilic butylglyceryl dextrans (DEX‐OX4) was...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied polymer science Vol. 138; no. 16
Main Authors: Bostanudin, Mohammad F., Muhamad Noor, Noor S., Sahudin, Shariza, Mat Lazim, Azwan, Tan, Suk Fei, Sarker, Md Zaidul I.
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 20-04-2021
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Toward the development of colloidal systems that can enhance transdermal permeation of hydrophilic actives, a material combining the non‐toxic of dextran with alkylglycerols permeation enhancing property has been designed. To this purpose, a range of amphiphilic butylglyceryl dextrans (DEX‐OX4) was synthesized via modification with n‐butylglycidyl ether with a degree of functionalization in the range 6.3%–35.7%. A reduced viscosity and an increased molecular weight of DEX‐OX4 were recorded when compared to the starting material. DEX‐OX4 was formulated into nanocarriers and loaded with α‐arbutin prior to characterization—the nanoparticles (180–220 nm size) were found to be close‐to‐spherical, stable at pH 5 and 7, with a loading capacity of 11.7%. Slower release of α‐arbutin from the nanoparticles was demonstrated when tested in acidic media. Lack of toxicity at application‐relevant concentrations and increased permeation were demonstrated by nanoparticles in vitro results against immortalized skin human keratinocytes cells (HaCaT).
Bibliography:Funding information
University of Cyberjaya, Grant/Award Number: CRG/04/11/2016
ISSN:0021-8995
1097-4628
DOI:10.1002/app.50235